ctDNA MRD as a Powerful and Potentially Actionable Biomarker

Time: 11:15 am
day: Day One


• Bridging the topics of ctDNA MRD assay technical development and clinical implementation
• How are new technical and translational findings being applied to inform clinical trial designs
• Updates on the latest exciting predictive data and trial designs to query ctDNA MRD as a predictive biomarker in breast cancer, colorectal cancer, bladder cancer and lung cancer